ClinicalTrials.gg
RecruitingNCT07853755Updated Oct 8, 2026

Motor Imagery-Assisted Pelvic Floor Muscle Training for Stress Urinary Incontinence in Postmenopausal Women

An interventional study of Pelvic Floor Muscle Training and Pelvic-Floor-Specific Kinesthetic Motor Imagery in Stress Urinary Incontinence (SUI), sponsored by Istanbul Medipol University Hospital. Recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 45 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-10-08.

Sponsored by Istanbul Medipol University Hospital · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Sep 2026; still recruiting 1 month later.
Updated Oct 8, 2026Now RecruitingSite recruiting status changed+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
45 Years to 65 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 49 studies in Urinary Incontinence, Stress with a site in Turkey — 15 open to participants now, 15 under way, none of them phase 3. Urinary Incontinence, Stress · Turkey.

Planned enrollment
18th of 41
60 · median 60
Started
2026
with 3 others
No phase
39 of 49
14 open now
Primary completion
2027-01
later than 13 of 14 live
Registered
49th of 49
by date

Among the 49 studies in Urinary Incontinence, Stress with a site in Turkey, this one is the 18th largest by planned enrollment of the 41 interventional ones that give a count, is one of 4 that started in 2026, is one of 39 with no phase, reaches primary completion later than 13 of the 14 other live ones, and was the 49th registered.

Urinary Incontinence, Stress

655 studies on the registry are indexed under Urinary Incontinence, Stress; 123 are open to participants now.

Browse Urinary Incontinence, Stress studies →

Open to participants now

15 of the 49 studies in Urinary Incontinence, Stress with a site in Turkey are open now. Recruiting first, the newest first:

9 more — sign in →

All 15 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 76 Urinary Incontinence, Stress studies recruiting now, 43 (57%) set no upper age limit and 18 (24%) stop at 75 or younger; 2 take children under 18; 16 take healthy volunteers.

This study: 45 Years to 65 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 49 studies in Urinary Incontinence, Stress with a site in Turkey, or all of them as a file.
02

Study summary

This study will evaluate whether adding mental rehearsal of pelvic floor muscle contractions to pelvic floor muscle training improves stress urinary incontinence in postmenopausal women. Stress urinary incontinence is urine leakage during activities such as coughing, sneezing, or physical exertion. Mental rehearsal involves imagining the sensation of a movement without physically performing it.

The study will include 60 women aged 45 to 65 years who have completed natural menopause and have stress urinary incontinence. Participants will be randomly assigned to one of two groups. Both groups will receive the same supervised pelvic floor muscle training twice a week for 12 weeks. Before performing the pelvic floor exercises, one group will imagine contracting and relaxing the pelvic floor muscles. The other group will imagine making and opening a fist with their dominant hand.

Assessments will take place before treatment and at the end of 12 weeks. The main outcome will be urinary incontinence symptom severity. Additional assessments will examine urine leakage frequency and amount, incontinence-related quality of life, and pelvic floor muscle electrical activity.

Read the detailed description

This randomized, parallel-group, active-controlled trial will investigate the added effect of pelvic-floor-specific kinesthetic motor imagery when combined with pelvic floor muscle training. Kinesthetic motor imagery focuses on imagining the bodily sensation of a movement.

Participants will be allocated in a 1:1 ratio using computer-generated block randomization, with allocation concealed in sequentially numbered, opaque, sealed envelopes. The outcome assessor will remain blinded to group allocation.

In the experimental group, participants will imagine the sensation of closing, squeezing, and lifting the pelvic floor muscles, followed by relaxation, immediately before performing the corresponding physical contractions. In the active comparator group, participants will perform kinesthetic imagery of making and opening a fist with the dominant hand before completing the same pelvic floor exercises. Imagery duration, physical exercise dose, and therapist contact will be matched between groups to examine the contribution of imagery specifically directed at the pelvic floor.

The intervention will comprise 24 supervised sessions on nonconsecutive days, each lasting approximately 30 minutes. No additional home exercise program will be prescribed.

The primary outcome will be the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form total score. Secondary outcomes will include mean daily stress urinary leakage episodes recorded in a three-day diary, urinary loss measured by a 24-hour pad test, the Incontinence Quality of Life questionnaire total score, and pelvic floor muscle electrical activity measured using intravaginal surface electromyography. Electromyography will be used for assessment only.

Baseline and week-12 measurements will be analyzed to compare changes over time between groups, including the group-by-time interaction.

03

Conditions studied

  • Stress Urinary Incontinence (SUI)

Keywords

  • Postmenopause
  • Kinesthetic Motor Imagery
  • Pelvic Floor Muscle Training
04

Who can participate

Ages eligible
45 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Women aged 45 to 60 years.
  • Natural , defined as the absence of menstruation for at least 12 consecutive months without a pathological, pharmacological, or surgical cause.
  • Physician-diagnosed stress urinary incontinence.
  • Sufficient cognitive and communication abilities to understand instructions in Turkish and complete the questionnaires and a three-day bladder/leakage diary.
  • A score of at least 30 on each of the visual and kinesthetic imagery subscales of the Kinesthetic and Visual Imagery Questionnaire-20 (KVIQ-20), assessed before randomization.

Exclusion criteria

Exclusion Criteria:

  • Urgency, mixed, overflow, or neurogenic urinary incontinence.
  • Stage III or IV pelvic organ prolapse according to the Pelvic Organ Prolapse Quantification (POP-Q) system.
  • Inability to correctly and voluntarily contract the pelvic floor muscles.
  • Active urinary tract or vaginal infection, unexplained hematuria, or vaginal bleeding.
  • Severe vaginal atrophy, vaginismus, genital lesions, or pelvic pain that prevents intravaginal assessment.
  • Previous surgery for stress urinary incontinence or previous pelvic radiotherapy.
  • Pelvic floor rehabilitation for urinary incontinence within the previous 12 months.
  • Neurological or cognitive disorders, or uncontrolled psychiatric illness, that could affect pelvic floor control, continence, or motor imagery ability.
  • Serious or uncontrolled systemic or musculoskeletal conditions that prevent safe participation in the exercise program.
  • Changes in hormone therapy within the previous six months or changes in medications affecting urinary system function within the previous three months.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Postmenopausal

Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Pelvic Floor Motor Imagery + Pelvic Floor Muscle Training

    Participants will receive pelvic-floor-specific kinesthetic motor imagery combined with supervised pelvic floor muscle training. Immediately before each physical pelvic floor contraction, participants will imagine the sensation of closing, squeezing, and lifting the pelvic floor muscles, followed by relaxation, without physically contracting during imagery. The program will include 24 supervised sessions over 12 weeks, delivered twice weekly on nonconsecutive days, with each session lasting approximately 30 minutes.

    Behavioral: Pelvic Floor Muscle Training · Behavioral: Pelvic-Floor-Specific Kinesthetic Motor Imagery

  • Active comparator
    Hand Motor Imagery + Pelvic Floor Muscle Training

    Participants will perform kinesthetic motor imagery of making and opening a fist with the dominant hand, without actual hand movement, immediately before each physical pelvic floor contraction. They will receive the same supervised pelvic floor muscle training as the experimental group. Imagery duration, physical exercise dose, and therapist contact will be matched between groups. The program will include 24 supervised sessions over 12 weeks, delivered twice weekly on nonconsecutive days, with each session lasting approximately 30 minutes.

    Behavioral: Pelvic Floor Muscle Training · Behavioral: Dominant-Hand Kinesthetic Motor Imagery

Interventions

  • BehavioralPelvic Floor Muscle Training

    Both groups will receive the same progressive, supervised pelvic floor muscle training program, including slow and fast contractions, graded contractions, and pre-contraction before coughing or physical effort (the Knack). Training will progress across three four-week phases, with increasing contraction demands and progression toward standing and functional activities. The program will be delivered as part of 24 supervised sessions over 12 weeks, twice weekly on nonconsecutive days. Each session, including the assigned motor imagery component, will last approximately 30 minutes. No additional home exercise program will be prescribed.

  • BehavioralPelvic-Floor-Specific Kinesthetic Motor Imagery

    Participants will mentally rehearse the sensation of closing, squeezing, and lifting the pelvic floor muscles around the urethra and vagina, followed by relaxation, without physically contracting during imagery. Kinesthetic imagery will be performed immediately before each corresponding physical pelvic floor contraction. This component will be integrated into all 24 supervised sessions over 12 weeks. Imagery duration and therapist contact will be matched to the dominant-hand imagery condition.

  • BehavioralDominant-Hand Kinesthetic Motor Imagery

    Participants will mentally rehearse the sensation of making and opening a fist with their dominant hand, without actual hand movement. This imagery will be performed immediately before each physical pelvic floor contraction and will be integrated into all 24 supervised sessions over 12 weeks. Imagery duration and therapist contact will be matched to the pelvic-floor-specific imagery condition. Participants will receive the same physical pelvic floor muscle training program as the experimental group.

06

What researchers measure

Primary outcomes

  1. International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF) Total Score

    Urinary incontinence severity will be assessed using the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQ-UI SF). The questionnaire assesses the frequency and amount of urinary leakage and its impact on everyday life over the previous four weeks. The total score is calculated by summing three scored items and ranges from 0 to 21, with higher scores indicating greater urinary incontinence severity.

    Time frame: Baseline (before the first treatment session) and at the end of the 12-week intervention.

Secondary outcomes

  1. Mean Daily Stress Urinary Leakage Episodes

    The mean number of stress urinary leakage episodes per day will be calculated using a bladder diary completed over three consecutive days before each assessment. Participants will record leakage associated with coughing, sneezing, laughing, lifting, or physical exertion. The total number of stress urinary leakage episodes recorded over three days will be divided by three. Results will be expressed as episodes per day, with higher values indicating more frequent leakage.

    Time frame: Baseline (before the first treatment session) and at the end of the 12-week intervention.

  2. Urinary Loss Measured by the 24-Hour Pad Test

    Urinary loss will be measured using a 24-hour pad test. Pads will be weighed before and after use using a calibrated scale, and the same pad type will be used at both assessments. The differences between used and dry pad weights will be summed to calculate total urinary loss over 24 hours. Results will be expressed in grams per 24 hours, with higher values indicating greater urinary loss.

    Time frame: Baseline (before the first treatment session) and at the end of the 12-week intervention.

  3. Incontinence Quality of Life Questionnaire (I-QOL) Total Score

    Incontinence-related quality of life will be assessed using the 22-item Incontinence Quality of Life questionnaire (I-QOL). The questionnaire covers avoidance and limiting behaviors, psychosocial impacts, and social embarrassment. The total score will be transformed to a scale ranging from 0 to 100, with higher scores indicating better incontinence-related quality of life.

    Time frame: Baseline (before the first treatment session) and at the end of the 12-week intervention.

  4. Mean Pelvic Floor Muscle Electrical Activity During Voluntary Contractions

    Pelvic floor muscle electrical activity will be assessed using intravaginal surface electromyography. Following a 60-second resting recording, participants will perform three maximal voluntary contractions lasting 10 seconds each, separated by 20-second rest intervals. The mean electrical activity during each contraction will be calculated, and the average of the three contraction values will be reported in microvolts. Assessments will be performed with an empty bladder in a supine position with the knees flexed, using standardized probe placement and device settings.

    Time frame: Baseline (before the first treatment session) and at the end of the 12-week intervention.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — There is currently no plan to share individual participant data. Study findings will be reported in aggregate form

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2026 (actual). Primary completion is estimated for Jan 2027, 3 months after the start.

Of 227 non-industry interventional studies with no phase under Urinary Incontinence, Stress, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 3 months is below that.

Counting every sponsor, half of 268 studies reached it within 19 months; a quarter within 9 and three quarters within 43.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 25, 2026
First posted
Oct 2, 2026
StartActual
Sep 28, 2026
Primary completionEst.
Jan 5, 2027
CompletionEst.
Jan 5, 2027
Last update
Oct 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 8, 2026
Sites
Istanbul Medipol University is now Recruiting
Oct 8, 2026
Registered
First appeared on the registry
Oct 2, 2026
Show all 2 updates
  1. Oct 8, 2026
    Not yet recruiting→Recruiting
    Istanbul Medipol University is now Recruiting
    + 2 other changes: verification date and date precision
  2. Oct 2, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07853755
Responsible party
gizem boztas (Assistant professor, Istanbul Medipol University Hospital) — Principal investigator
First posted
Oct 2, 2026
Start date
Sep 28, 2026
Primary completion
Jan 5, 2027 (estimated)
Completion
Jan 5, 2027 (estimated)
Last update
Oct 8, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion